Molecular Formula | C75H118N20O22S |
Molar Mass | 1683.93 |
Density | 1.334±0.06 g/cm3(Predicted) |
Boling Point | 1982.4±65.0 °C(Predicted) |
Appearance | solid |
pKa | 3.12±0.10(Predicted) |
Storage Condition | -20°C |
In vitro study | NFAT Inhibitor treatment significantly inhibits nuclear translocation of NFATc1 for 24 hours. Long-term treatment with VIVIT significantly inhibits the cytoplasmic levels of cathepsin K, TRAP, and MMP-9. Western Blot Analysis Cell Line: Human peripheral blood CD14 + monocytes Concentration: 10 μM Incubation Time: 24 hours or 21 days Result: Short-term treatment with 10 μM, significantly inhibited nuclear translocation of NFATc1. Long-term treatment, significantly inhibited the cytoplasmic levels of cathepsin K, TRAP, and MMP-9. |
Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 0.594 ml | 2.969 ml | 5.938 ml |
5 mM | 0.119 ml | 0.594 ml | 1.188 ml |
10 mM | 0.059 ml | 0.297 ml | 0.594 ml |
5 mM | 0.012 ml | 0.059 ml | 0.119 ml |